Tags

Type your tag names separated by a space and hit enter

Haemorrhagic complications associated with reduced alpha2-plasmin inhibitor during imatinib use in a patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Leuk Res. 2009 Jun; 33(6):867-9.LR

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Letter

Language

eng

PubMed ID

18951628

Citation

Matsue, Kosei, et al. "Haemorrhagic Complications Associated With Reduced Alpha2-plasmin Inhibitor During Imatinib Use in a Patient With Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia." Leukemia Research, vol. 33, no. 6, 2009, pp. 867-9.
Matsue K, Aoki T, Odawara J, et al. Haemorrhagic complications associated with reduced alpha2-plasmin inhibitor during imatinib use in a patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia. Leuk Res. 2009;33(6):867-9.
Matsue, K., Aoki, T., Odawara, J., Kimura, S., Yamakura, M., & Takeuchi, M. (2009). Haemorrhagic complications associated with reduced alpha2-plasmin inhibitor during imatinib use in a patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia. Leukemia Research, 33(6), 867-9. https://doi.org/10.1016/j.leukres.2008.09.017
Matsue K, et al. Haemorrhagic Complications Associated With Reduced Alpha2-plasmin Inhibitor During Imatinib Use in a Patient With Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia. Leuk Res. 2009;33(6):867-9. PubMed PMID: 18951628.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Haemorrhagic complications associated with reduced alpha2-plasmin inhibitor during imatinib use in a patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia. AU - Matsue,Kosei, AU - Aoki,Takatoshi, AU - Odawara,Jun, AU - Kimura,Shun-ichi, AU - Yamakura,Masayuki, AU - Takeuchi,Masami, Y1 - 2008/10/31/ PY - 2008/07/31/received PY - 2008/07/31/revised PY - 2008/09/02/accepted PY - 2008/10/28/pubmed PY - 2009/4/28/medline PY - 2008/10/28/entrez SP - 867 EP - 9 JF - Leukemia research JO - Leuk Res VL - 33 IS - 6 SN - 1873-5835 UR - https://www.unboundmedicine.com/medline/citation/18951628/Haemorrhagic_complications_associated_with_reduced_alpha2_plasmin_inhibitor_during_imatinib_use_in_a_patient_with_Philadelphia_chromosome_positive_acute_lymphoblastic_leukaemia_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0145-2126(08)00392-5 DB - PRIME DP - Unbound Medicine ER -